It would probably be good to touch on:
- To what degree we can attribute these results to Bisantrene (over Clofarabine and Fludarabine).
- Comparison response rates seen in other anti-cancer P2 drugs that go on to get picked up by BP
- Can we expect RC220 to have similar efficacy, or perhaps fewer adverse events (lower risk of infection)?
- Highlight the curious lack of cardiotoxicity despite Clofarabine being highly cardiotoxic!
- Any exploratory, or circumstantial FTO insights - pretty please
- Try to include some $$$ numbers - this needs to appeal to all investors, not just the altruistic
- Forums
- ASX - By Stock
- RAC
- ASH2023 - Sheba 2.0
ASH2023 - Sheba 2.0, page-51
-
- There are more pages in this discussion • 106 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.44 |
Change
-0.010(0.69%) |
Mkt cap ! $241.2M |
Open | High | Low | Value | Volume |
$1.45 | $1.49 | $1.43 | $110.9K | 76.03K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 898 | $1.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.49 | 3500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 898 | 1.435 |
1 | 1135 | 1.425 |
2 | 850 | 1.410 |
1 | 206 | 1.405 |
2 | 6570 | 1.400 |
Price($) | Vol. | No. |
---|---|---|
1.490 | 3500 | 1 |
1.495 | 3344 | 1 |
1.500 | 13333 | 1 |
1.520 | 10001 | 1 |
1.535 | 4438 | 1 |
Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.44 |
  |
Change
-0.010 ( 0.44 %) |
|||
Open | High | Low | Volume | ||
$1.43 | $1.49 | $1.43 | 9906 | ||
Last updated 15.59pm 30/05/2024 ? |
Featured News
RAC (ASX) Chart |
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin & Ramón Jiménez Serrano, Managing Director & Executive Director
Ryan Parkin & Ramón Jiménez Serrano
Managing Director & Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online